methyl maslinate: isolated from the radix of Vaccinium scopulorum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Vaccinium | genus | A plant genus of the family ERICACEAE known for species with edible fruits.[MeSH] | Ericaceae | The heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH] |
Vaccinium scopulorum | species | [no description available] | Ericaceae | The heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 609113 |
MeSH ID | M0209128 |
Synonym |
---|
methyl maslinate |
maslinic acid methyl ester |
methyl 2,3-dihydroxyolean-12-en-28-oate # |
olean-12-en-28-oic acid, 2,3-dihydroxy-, methyl ester, (2.alpha.,3.alpha.)- |
OTDUGESKRJHFHR-UHFFFAOYSA-N |
olean-12-en-28-oic acid, 2.alpha.,3.alpha.-dihydroxy-, methyl ester |
methyl 3-epimaslinate |
Excerpt | Relevance | Reference |
---|---|---|
" They displayed significant, dose-response vasodepressor effect and sinus bradicardia, most prominent for OA and MM." | ( Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol. Mipando, M; Shode, FO; Somova, LI, 2004) | 0.56 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.82) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |